s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
8-K
Director or officer change
Filed
Friday, June 26, 2026
Period
Jun 22, 2026
Accession number
0001493152-26-030306
Documents
Current report filing
8-K
Data files
3
Financial data and other files for software
101.SCH
XBRL Schema File
EX-101.SCH
101.LAB
XBRL Label File
EX-101.LAB
101.PRE
XBRL Presentation File
EX-101.PRE
On sec.gov
Filing index
All files
Complete submission text
SGML header